Clik here to view.
Lead underwriters start Candy Crush maker with "buy" ratings
(Reuters) - The three lead underwriters of King Digital Entertainment Plc's IPO started coverage of the stock with "buy" ratings or the equivalent, two days ahead of the release of the "Candy Crush...
View ArticleClik here to view.
AstraZeneca fights Pfizer bid by predicting sales surge - eventually
LONDON (Reuters) - AstraZeneca Plc laid out its defense against Pfizer Inc's $106-billion takeover approach on Tuesday by predicting its sales would rise by three quarters over the next decade,...
View ArticleClik here to view.
Twitter shares plumb new lows as stock lock-up expires
(Reuters) - Shares of Twitter Inc sank 18 percent to a new low in frenzied trading on Tuesday, wiping out more than $4 billion of its market value, as early investors sold stock in the messaging...
View ArticleClik here to view.
Shareholders set to grill Allianz management on Pimco
MUNICH (Reuters) - Top Allianz executives are set to face a grilling on Wednesday from shareholders worried about a wobbly performance at its Pimco fund management unit.
View ArticleClik here to view.
HTC shares fall after guidance announcement
TAIPEI (Reuters) - Shares of Taiwan's HTC Corp opened 4 percent lower on Wednesday after the struggling smartphone maker said it is likely to break even or book a profit in the first half.
View ArticleClik here to view.
Insurer Allianz defends Pimco after investors take flight
MUNICH (Reuters) - Europe's biggest insurer Allianz defended its U.S. asset management business Pimco on Wednesday as it came under fire for failing to stem the flow of heavy investor withdrawals.
View ArticleClik here to view.
AstraZeneca takeover would benefit science: Pfizer
LONDON (Reuters) - Pfizer sought to allay fears that its proposed $106 billion takeover of AstraZeneca would deal a blow to drug research, saying the new company would bolster innovative science and...
View ArticleClik here to view.
Fiat Chrysler shares tumble on strategic plan doubts
MILAN/PARIS (Reuters) - Fiat Chrysler's shares fell sharply on Wednesday as analysts questioned whether the carmaker could achieve Chief Executive Sergio Marchionne's new targets - and how his...
View ArticleClik here to view.
'Candy Crush' maker King serves up bittersweet results, shares fall
(Reuters) - King Digital Entertainment Plc's stock plummeted more than 13 percent on Wednesday as signs that the company may be losing steam overshadowed better-than-expected quarterly results from...
View ArticleClik here to view.
Cheetah Mobile shares rise about 13 percent in debut
(Reuters) - Cheetah Mobile Inc's shares rose about 13 percent in their market debut, valuing the Chinese security software maker at about $2.2 billion, after its initial public offering was priced...
View ArticleClik here to view.
AMC Networks forecasts slower advertising growth
(Reuters) - Cable TV broadcaster AMC Networks Inc said it expects slower advertising growth this quarter as its latest series, "Turn", draws fewer viewers than its older hits, sending its shares down...
View ArticleClik here to view.
Molycorp slumps 17 percent to record low on bigger quarterly loss
(Reuters) - Molycorp Inc shares slumped 17 percent on Thursday in the wake of the U.S.-based rare earths producer's results a day earlier which showed a bigger first-quarter loss and production...
View ArticleClik here to view.
UK research foundation concerned about Pfizer bid for AstraZeneca: FT
(Reuters) - Wellcome Trust, Britain's biggest medical research foundation said it had "major concerns" about U.S. drug major Pfizer's 63 billion pound offer for AstraZeneca , the Financial Times...
View ArticleClik here to view.
Pfizer defends 'powerhouse' Astra deal as CEO braces for grilling
LONDON (Reuters) - Pfizer defended the business case behind its plan to acquire AstraZeneca on Monday and questioned the UK drugmaker's ability to stand alone for much longer as the New York-based...
View ArticleClik here to view.
UK lawmakers give Pfizer stick as it waves carrot at AstraZeneca
LONDON (Reuters) - U.S. drugmaker Pfizer hinted it could raise its proposed $106 billion offer if AstraZeneca would only engage in talks, as its boss was grilled by UK lawmakers on his commitment to...
View ArticleClik here to view.
Pfizer pledges to ringfence key new drugs in AstraZeneca deal
LONDON (Reuters) - Pfizer said it would ringfence the development of important drugs if it acquired AstraZeneca , rejecting a charge from the British company that a takeover would disrupt important...
View ArticleClik here to view.
Pfizer raises bid for AstraZeneca to $117 billion
LONDON (Reuters) - U.S. drugmaker Pfizer said on Sunday it had raised its offer for British rival AstraZeneca to 69.3 billion pounds ($116.6 billion), or 55 pounds a share, and would walk away if...
View ArticleClik here to view.
AstraZeneca rejects Pfizer's take-it-or-leave-it offer
LONDON (Reuters) - Britain's AstraZeneca on Monday rejected a sweetened and "final" offer from Pfizer, puncturing the U.S. drugmaker's plan for a merger to create the world's biggest pharmaceuticals...
View ArticleClik here to view.
See you later? Slim Pfizer deal hopes prop up AstraZeneca
LONDON (Reuters) - Pfizer's chances of striking a deal to buy AstraZeneca in the coming days look vanishingly small, but the notion it could return later this year is propping up the British...
View ArticleClik here to view.
Pfizer walks away from $118 billion AstraZeneca takeover fight
LONDON/NEW YORK (Reuters) - Pfizer abandoned its attempt to buy AstraZeneca for nearly 70 billion pounds ($118 billion) on Monday as a deadline approached without a last-minute change of heart by the...
View Article